ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

$5.85
+0.11 (+1.92%)
As of Jun 23, 2:30 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +666.0% upside
Low Target $32.90
Average Target $44.81
High Target $56.58
Current Price $5.85
Current
$5.85
Target
$44.81
$32.90 $44.81 avg $56.58
Scenario Analysis
Bear Case
$32.90
462.4%
Low target
Base Case
$44.81
+666.0%
Avg target
Bull Case
$56.58
+867.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.79
-13.8% from high
52-Week Low
$2.75
+113.1% from low
50-Day SMA
$3.99
+46.6% vs SMA
RSI (14)
58.5
Neutral
Target vs 52W High
$44.81
+559.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -21.3%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -11.7%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -48.9%
WAT
Waters Corp
Buy 28 57% $189.60 -46.9%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -51.6%
ILMN
Illumina Inc
Buy 28 61% $169.36 +2.7%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -59.5%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -85.3%